KFGK
Keystone Financial Group (Kentucky)’s Inovio Pharmaceuticals INO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.5K | Hold |
10,073
| – | – | ﹤0.01% | 427 |
|
|
2025
Q1 | $16.4K | Hold |
10,073
| – | – | ﹤0.01% | 393 |
|
|
2024
Q4 | $18.4K | Hold |
10,073
| – | – | ﹤0.01% | 389 |
|
|
2024
Q3 | $58.2K | Sell |
10,073
-15
| -0.1% | -$87 | 0.01% | 367 |
|
|
2024
Q2 | $81.5K | Sell |
10,088
-219
| -2% | -$1.77K | 0.03% | 162 |
|
|
2024
Q1 | $143K | Sell |
10,307
-112,430
| -92% | -$1.56M | 0.02% | 339 |
|
|
2023
Q4 | $62.6K | Buy |
122,737
+12,840
| +12% | +$6.55K | 0.01% | 294 |
|
|
2023
Q3 | $42.8K | Buy |
109,897
+3,500
| +3% | +$1.36K | 0.01% | 298 |
|
|
2023
Q2 | $47.5K | Buy |
+106,397
| New | +$47.5K | 0.01% | 299 |
|
|
2022
Q4 | $155K | Buy |
99,288
+25,230
| +34% | +$39.4K | 0.03% | 270 |
|
|
2022
Q3 | $128K | Sell |
74,058
-114
| -0.2% | -$197 | 0.03% | 276 |
|
|
2022
Q2 | $128K | Buy |
74,172
+1,750
| +2% | +$3.02K | 0.03% | 283 |
|
|
2022
Q1 | $260K | Buy |
72,422
+6,000
| +9% | +$21.5K | 0.04% | 250 |
|
|
2021
Q4 | $331K | Buy |
66,422
+3,250
| +5% | +$16.2K | 0.05% | 223 |
|
|
2021
Q3 | $452K | Buy |
63,172
+2,460
| +4% | +$17.6K | 0.08% | 175 |
|
|
2021
Q2 | $563K | Buy |
60,712
+4,457
| +8% | +$41.3K | 0.1% | 151 |
|
|
2021
Q1 | $522K | Buy |
56,255
+17,180
| +44% | +$159K | 0.1% | 151 |
|
|
2020
Q4 | $346K | Buy |
39,075
+6,600
| +20% | +$58.4K | 0.07% | 178 |
|
|
2020
Q3 | $377K | Buy |
+32,475
| New | +$377K | 0.09% | 157 |
|